Musk's Neuralink cleared for human test of brain implants

The company said clearance from the US Food and Drug Administration for its first in-human clinical study is "an important first step" for its technology

Musk's Neuralink cleared for human test of brain implants (Photo: DW)
Musk's Neuralink cleared for human test of brain implants (Photo: DW)
user

DW

Elon Musk's brain-implant company Neuralink on Thursday said it received the US Food and Drug Administration's (FDA) approval to launch first-in-human clinical study.

The company announced the decision on Twitter, saying the approval "represents an important first step that will one day allow our technology to help many people."

On at least four occasions since 2019, Musk has predicted that his medical device company would soon start human trial of a brain impant to treat intractable conditions like paralysis and blindness.

But the company, founded in 2016, did not seek approval until early 2022.

Follow us on: Facebook, Twitter, Google News, Instagram 

Join our official telegram channel (@nationalherald) and stay updated with the latest headlines